# A Single Ascending Dose Study of ACT-541468 in Healthy Male Subjects

> **NCT02919319** · PHASE1 · COMPLETED · sponsor: **Idorsia Pharmaceuticals Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** ACT-541468 (Formulation A)
- **DRUG:** ACT-541468 (Formulation B)
- **DRUG:** Placebo (Formulation A)
- **DRUG:** Placebo (Formulation B)
- **DRUG:** 14C-labeled ACT-541468
- **DRUG:** Placebo tracer

## Key facts

- **NCT ID:** NCT02919319
- **Lead sponsor:** Idorsia Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-01
- **Primary completion:** 2015-05-01
- **Final completion:** 2015-05-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02919319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02919319, "A Single Ascending Dose Study of ACT-541468 in Healthy Male Subjects". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02919319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*